Literature DB >> 23737698

Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma.

C W Hong1, S K Libutti, B J Wood.   

Abstract

Radiofrequency ablation (rfa) is a standard treatment for small, unresectable hepatocellular carcinomas (hccs). However, rfa for larger tumours is less successful, and intravenous lyso-thermosensitive liposomal doxorubicin during rfa is one technique postulated to potentially address that limitation. This drug-plus-device combination therapy was used to completely treat a hcc in a patient who underwent liver transplantation 79 days later.

Entities:  

Keywords:  ablation; doxorubicin; hepatocellular carcinoma; liposomes; rfa

Year:  2013        PMID： 23737698      PMCID： PMC3671035          DOI： 10.3747/co.20.1266

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


  12 in total

1.  Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ayele Negussie; Bradford J Wood; Frank Rattay; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 2.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

3.  Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.

Authors:  Ana M Ponce; Benjamin L Viglianti; Daohai Yu; Pavel S Yarmolenko; Charles R Michelich; Janet Woo; Marcel B Bally; Mark W Dewhirst
Journal:  J Natl Cancer Inst       Date:  2007-01-03       Impact factor: 13.506

4.  Resection or ablation of small hepatocellular carcinoma: what is the better treatment?

Authors:  Henrik Petrowsky; Ronald W Busuttil
Journal:  J Hepatol       Date:  2008-08-15       Impact factor: 25.083

5.  Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model.

Authors:  Ashish Ranjan; Genevieve C Jacobs; David L Woods; Ayele H Negussie; Ari Partanen; Pavel S Yarmolenko; Carmen E Gacchina; Karun V Sharma; Victor Frenkel; Bradford J Wood; Matthew R Dreher
Journal:  J Control Release       Date:  2011-12-21       Impact factor: 9.776

6.  Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.

Authors:  H K Lim; D Choi; W J Lee; S H Kim; S J Lee; H J Jang; J H Lee; J H Lim; I W Choo
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

7.  Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Authors:  David S K Lu; Nam C Yu; Steven S Raman; Charles Lassman; Myron J Tong; Carolyn Britten; Francisco Durazo; Sammy Saab; Steven Han; Richard Finn; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

8.  Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.

Authors:  Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Sara Massironi; Alice Colucci; Dario Conte; Piergiorgio Duca
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

Review 9.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  6 in total

1.  A targeted approach to cancer imaging and therapy.

Authors:  Chun Li
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

Review 2.  Nanomedical engineering: shaping future nanomedicines.

Authors:  Dandan Luo; Kevin A Carter; Jonathan F Lovell
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-11-06

3.  Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.

Authors:  Kavindra Nath; David S Nelson; Daniel F Heitjan; Dennis B Leeper; Rong Zhou; Jerry D Glickson
Journal:  NMR Biomed       Date:  2014-12-12       Impact factor: 4.044

4.  Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.

Authors:  Cheng William Hong; Lucy Chow; Evrim B Turkbey; Riccardo Lencioni; Steven K Libutti; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2015-07-31       Impact factor: 2.740

Review 5.  Nanotechnology applications in thoracic surgery.

Authors:  Sophie C Hofferberth; Mark W Grinstaff; Yolonda L Colson
Journal:  Eur J Cardiothorac Surg       Date:  2016-02-02       Impact factor: 4.191

6.  Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma.

Authors:  Ying-Hsia Shih; Xi-Zhang Lin; Chung-Hsin Yeh; Cheng-Liang Peng; Ming-Jium Shieh; Wuu-Jyh Lin; Tsai-Yueh Luo
Journal:  Int J Nanomedicine       Date:  2014-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.